Trial Profile
Doxazosin in the Treatment of Co-occuring PTSD and Alcohol Use Disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Jan 2021
Price :
$35
*
At a glance
- Drugs Doxazosin (Primary)
- Indications Alcoholism; Post-traumatic stress disorders
- Focus Therapeutic Use
- 02 Jan 2020 Status changed from active, no longer recruiting to completed.
- 03 Sep 2019 Planned End Date changed from 1 Oct 2019 to 1 Jan 2020.
- 03 Sep 2019 Planned primary completion date changed from 1 Sep 2019 to 1 Dec 2019.